Inhibition of pathologic retinal neovascularization by -defensins
Authors:
- Khalil BdeirKBKhalil Bdeir
- Douglas B. CinesDCDouglas B. Cines
- Franz FogtFFFranz Fogt
- Yasmina BdeirYBYasmina Bdeir
- Jacek LubkowskiJLJacek Lubkowski
- Wuyuan LuWLWuyuan Lu
- Klaus T. PreissnerKPKlaus T. Preissner
- Hans-Peter HammesHHHans-Peter Hammes
- Triantafyllos ChavakisTCTriantafyllos Chavakis
- 1 December 2005
- journal article
- Published by American Society of Hematology in Blood
- Vol. 106 (12) , 3831-3838
Abstract
Proliferative retinopathies, such as those complicating prematurity and diabetes, are major causes of blindness. A prominent feature of these retinopathies is excessive neovascularization, which is orchestrated by the hypoxia-induced vascular endothelial growth factor (VEGF) stimulating endothelial cells and the integrin-mediated adhesive interactions of endothelial cells with extracellular matrix components such as fibronectin (FN). Recently, we demonstrated that α-defensins interfere with α5β1–FN interactions and dependent endothelial cell functions. Here, α-defensins were studied in hypoxia-induced proliferative retinopathy. In vitro, α-defensins specifically inhibited α5β1-integrin–dependent migration of bovine retinal endothelial cells (BRECs) to FN, attenuated the VEGF-stimulated increase in endothelial permeability, and blocked BREC proliferation and capillary sprout formation in 3-dimensional fibrin-matrices. An up-regulation of β1-integrin and FN was observed in the retinal vessels in the mouse model of hypoxia-induced retinal angiogenesis. Systemic and local administration of α-defensins reduced retinal neovascularization by 45% and 60%, respectively, and this effect was comparable to the inhibitory effect of α5β1-blocking antibody. α-Defensins were detected in human diabetic retinas associated with normal retinal vessels but were absent from proliferative lesions. Together, these data show that α-defensins inhibit pathologic retinal neovascularization in vivo and may provide a clinically efficient strategy against proliferative retinopathies.Keywords
This publication has 49 references indexed in Scilit:
- Endostatin modulates VEGF-mediated barrier dysfunction in the retinal microvascular endotheliumExperimental Eye Research, 2005
- Regulation of neovascularization by human neutrophil peptides (α‐defensins): a link between inflammation and angiogenesisThe FASEB Journal, 2004
- The functional role of blood platelet components in angiogenesisThrombosis and Haemostasis, 2004
- Ocular neovascularization: a valuable model systemOncogene, 2003
- From pro defensins to defensins: synthesis and characterization of human neutrophil pro α‐defensin‐1 and its mature domainChemical Biology & Drug Design, 2003
- VEGF‐induced paracellular permeability in cultured endothelial cells involves urokinase and its receptorThe FASEB Journal, 2003
- PRECLINICAL AND PHASE 1A CLINICAL EVALUATION OF AN ANTI-VEGF PEGYLATED APTAMER (EYE001) FOR THE TREATMENT OF EXUDATIVE AGE-RELATED MACULAR DEGENERATIONRetina, 2002
- Vascular Endothelial Growth Factor (VEGF)-Induced Retinal Vascular Permeability Is Mediated by Intercellular Adhesion Molecule-1 (ICAM-1)The American Journal of Pathology, 2000
- Effects of intraocular or systemic administration of neutralizing antibody against vascular endothelial growth factor on the murine experimental model of retinopathyLife Sciences, 1999
- Defensins: a family of antimicrobial and cytotoxic peptidesToxicology, 1994